OREANDA-NEWS. November 12, 2014. General Steel Holdings, Inc. ("General Steel" or the "Company") (NYSE: GSI), a leading non-state-owned steel producer in China, announced today that the New York Stock Exchange (the "NYSE") has notified the Company that it has fallen below the NYSE's continued listing standard that requires a minimum average closing price of USD1.00 per share over a 30 consecutive trading day period. As of October 21, 2014, the 30 trading-day average closing price of the Company was USD 0.99.

Pursuant to NYSE rules, the Company has a cure period of six months from receipt of the notification on October 24, 2014, to cure its non-compliance of the minimum share price standard. The Company can regain compliance on an accelerated basis if its common stock has a share price at or above USD 1.00 on the last trading day of any calendar month within the cure period and the average share price over the 30 trading days preceding the end of that month is also at or above USD 1.00.

In addition, pursuant to NYSE rules, the Company has 10 business days from the receipt of the NYSE's notification to submit its intent to cure this non-compliance. The Company intends to submit a plan outlining the actions it intends to complete to increase its share price, and will notify the NYSE that it intends to cure the non-compliance within the prescribed timeframe.

The NYSE suggests that the Company seriously consider implementation of a reverse stock split, which the Company received shareholder approval for at its annual general meeting on December 27, 2013, in order to effect a cure of its non-compliance within the appropriate timeframe and to avoid any future recurrence of non-compliance with the NYSE's share price standard. If the Company decides to implement a reverse stock split, it must so inform the NYSE in the above referenced notification and must implement the reverse stock split within the six-month cure period. The Company intends to actively monitor the closing price of its common stock during the cure period and will evaluate available options to resolve this non-compliance and regain compliance with the applicable NYSE rules.

The Company's common stock will continue to be listed and traded on the NYSE during the six-month cure period, but will be assigned a ".BC" indicator by the NYSE to signify that the Company is not currently in compliance with the NYSE's continued listing standards. The Company's business operations and United States Securities and Exchange Commission reporting requirements are not affected by the receipt of the NYSE's notification.